| ABOUT BAYBIOGET INVOLVEDEVENT CENTER
MEMBER CENTERINFORMATION CENTERMEDIA CENTERCAREER CENTER |
Regulatory Environment for Pain Therapeutics Sponsored by:
Pain treatment is big business, with several multi-billion dollar per year pain therapeutics on the market, and several others with sales of more than $100 million per year. Misuse and abuse of pain drugs is also a big problem. According to the FDA, the misuse and abuse of pain therapies has increased significantly in the past five years. Looking to reverse this trend, the FDA is requiring manufacturers of opioid products to implement Risk Evaluation and Mitigation (REMS) strategies, which the agency is in the process of developing. Come hear our panel of experts discuss how the new REMS guidelines will change the landscape of pain therapies. Panel Moderator: Panel Speakers:
Registrations: If you are an employee of a Partner or Sponsor company, please contact Program Director, Misha Tsirulnikov to obtain your complimentary registration. On-line reservations: CLICK HERE Reservations by mail or fax: CLICK HERE
Is your company a member? Click here to check. See how your company can save money by becoming a BayBio member! |